Tumor residing B7-H3+ DCs, derived from lung adenocarcinoma patient samples, exhibited significantly restricted T-cell activation capacity, decreased IL-12, and increased IL-10 secretion [40]. The gene discussed is CD276; the disease is lung adenocarcinoma.